Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates

Go back to Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 199.71 +3.13 (1.59%)
Previous Close $196.58    52 Week High $333.65 
Open $199.48    52 Week Low $223.02 
Day High $200.98    P/E 25.57 
Day Low $194.74    EPS $7.81 
Volume 1,675,269       

(NASDAQ: STOK) Delayed: 30.97 -0.03 (0.1%)
Previous Close $31.00    52 Week High
Open $31.37    52 Week Low
Day High $31.61    P/E N/A 
Day Low $30.91    EPS
Volume 617,217